What is the recommended treatment for urinary tract infections (UTIs) in pregnant women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urinary Tract Infections in Pregnant Women

For pregnant women with urinary tract infections, first-line treatment options include cephalosporins, nitrofurantoin, or fosfomycin, with a treatment duration of 7-14 days to ensure complete eradication of the infection. 1

Diagnostic Considerations

  • All pregnant women should be screened for bacteriuria with urine culture, as asymptomatic bacteriuria must be treated in every case due to the high risk of progression to pyelonephritis 2, 3
  • The presence of Group B Streptococcus (GBS) bacteriuria in any concentration during pregnancy requires treatment and subsequent intrapartum GBS prophylaxis during labor 1
  • Urine culture should be obtained before initiating treatment to guide antibiotic selection 1, 4

First-Line Treatment Options

Lower UTI/Cystitis

  • Nitrofurantoin 100 mg twice daily for 7 days (avoid in suspected pyelonephritis and near term) 1, 4
  • Fosfomycin trometamol 3 g single dose 1, 4
  • Cephalexin 500 mg four times daily for 7-14 days 1
  • Cefpodoxime or cefuroxime for 7-14 days 1

Pyelonephritis

  • Initial parenteral therapy is recommended for severe infections or pyelonephritis 1
  • Appropriate options include:
    • Ceftriaxone 1-2 g once daily 4
    • Amoxicillin combined with an aminoglycoside 3
    • Transition to oral therapy after clinical improvement 1

Medications to Avoid During Pregnancy

  • Trimethoprim and trimethoprim-sulfamethoxazole should be avoided during the first trimester due to potential teratogenic effects 1, 5
  • Trimethoprim-sulfamethoxazole should also be avoided in the last trimester 4
  • Fluoroquinolones should be avoided throughout pregnancy due to potential adverse effects on fetal development 1, 4

Follow-up and Monitoring

  • Urine cultures should be repeated 7 days following therapy to assess cure or failure 6
  • Pregnant women with recurrent UTIs may require closer monitoring and different management strategies 3

Special Considerations

  • Asymptomatic bacteriuria in pregnancy must be treated to prevent complications, unlike in non-pregnant women 2, 3
  • Delaying treatment in pregnant women with symptomatic UTI increases the risk of pyelonephritis and adverse pregnancy outcomes 1
  • Antibiotic choice should be guided by local resistance patterns and patient-specific factors such as allergies 1, 4

Potential Complications if Untreated

  • Increased risk of pyelonephritis 2, 3
  • Potential for preterm delivery and low birth weight 7, 3
  • Maternal complications including sepsis 3

Treatment Duration

  • For lower UTIs: 7-14 days of therapy is recommended 1
  • For pyelonephritis: 14 days of total therapy (initial parenteral followed by oral) 1, 4

UTIs during pregnancy require prompt diagnosis and appropriate antibiotic therapy to prevent complications for both mother and fetus. The choice of antibiotic should balance efficacy against potential risks to the developing fetus.

References

Guideline

Treatment of UTI During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Urinary tract infections in pregnancy.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2023

Guideline

Antibiotic Treatment for Pyuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Recommended treatment for urinary tract infection in pregnancy.

The Annals of pharmacotherapy, 1994

Research

Treatments for symptomatic urinary tract infections during pregnancy.

The Cochrane database of systematic reviews, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.